ACTR-62. A PHASE II STUDY OF TUMOR TREATING FIELDS (TTFIELDS) WITH TEMOZOLOMIDE IN PATIENTS WITH LOW-GRADE GLIOMAS

Approximately 2,000 to 3,000 adults are diagnosed with low-grade gliomas (LGGs) annually in the United States, with a median overall survival ranging from 3–9 years. Radiation and chemotherapy are used to treat LGGs but can increase the risk of transformation to high-grade tumors (HGG) and cause cog...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Juarez, Tiffany, Boucher, Najee, Heng, Annie, Gill, Jaya, Nguyen, Minhdan, Truong, Judy, Saria, Marlon, Achrol, Achal, Barkhoudarian, Garni, Kelly, Daniel, Kesari, Santosh
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692887/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.051
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados